Dermira, Inc. (NASDAQ: DERM)
Rowley Law PLLC is investigating potential securities law violations by Dermira, Inc. (NASDAQ: DERM) and its board of directors concerning the proposed acquisition of the company by Eli Lilly and Company (NYSE: LLY). Stockholders will receive $18.75 per share of Dermira, Inc. common stock that they hold. The transaction is valued at approximately $1.1 billion